These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18301267)

  • 1. The potential use of curcumin in management of chronic disease: too good to be true?
    Alpers DH
    Curr Opin Gastroenterol; 2008 Mar; 24(2):173-5. PubMed ID: 18301267
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological treatment of functional bowel disorders: any light at the end of the tunnel?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):669-70. PubMed ID: 18835367
    [No Abstract]   [Full Text] [Related]  

  • 3. COMPLEMENTARY AND ALTERNATIVE MEDICINE: A WORLD TO BE EXPLORED.
    Damião AOMC
    Arq Gastroenterol; 2017; 54(3):175-176. PubMed ID: 28876368
    [No Abstract]   [Full Text] [Related]  

  • 4. Ion channels as targets for treatment of gastrointestinal motility disorders.
    Farrugia G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
    [No Abstract]   [Full Text] [Related]  

  • 5. Curcumin: the potential for efficacy in gastrointestinal diseases.
    Irving GR; Karmokar A; Berry DP; Brown K; Steward WP
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):519-34. PubMed ID: 22122768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
    Aggarwal BB; Sung B
    Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forward peristalsis!--rapid progress in translational gastrointestinal pharmacology.
    Blackshaw LA; Aziz Q
    Curr Opin Pharmacol; 2011 Dec; 11(6):573-4. PubMed ID: 22000934
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary and gastrointestinal systems medications.
    Schryvers O; Nance PW
    Phys Med Rehabil Clin N Am; 1999 May; 10(2):473-92, ix-x. PubMed ID: 10370942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic receptors as future targets for treatment of functional GI disorders.
    Burnstock G
    Gut; 2008 Sep; 57(9):1193-4. PubMed ID: 18719131
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs targeting functional bowel disorders: insights from animal studies.
    Sanger GJ; Hicks GA
    Curr Opin Pharmacol; 2002 Dec; 2(6):678-83. PubMed ID: 12482730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin and the cellular stress response in free radical-related diseases.
    Calabrese V; Bates TE; Mancuso C; Cornelius C; Ventimiglia B; Cambria MT; Di Renzo L; De Lorenzo A; Dinkova-Kostova AT
    Mol Nutr Food Res; 2008 Sep; 52(9):1062-73. PubMed ID: 18792015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in gastrointestinal pharmacotherapy--who would have thought?
    Berardi RR
    Ann Pharmacother; 2007 Jun; 41(6):1053-5. PubMed ID: 17504831
    [No Abstract]   [Full Text] [Related]  

  • 13. [Motility-modifying drugs].
    Storr M; Allescher HD
    Internist (Berl); 2000 Dec; 41(12):1318-24, 1326-30. PubMed ID: 11189067
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastrointestinal neuropharmacology: identification of therapeutic targets.
    Furness JB; Sanger GJ
    Curr Opin Pharmacol; 2002 Dec; 2(6):609-11. PubMed ID: 12482721
    [No Abstract]   [Full Text] [Related]  

  • 15. Minor digestive disturbances.
    Copper P
    Midwife Health Visit Community Nurse; 1977 Aug; 13(8):263. PubMed ID: 587248
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
    Jovanović-Mićić D; Samardzić R; Beleslin B
    Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In brief: pancreatic enzyme products.
    Med Lett Drugs Ther; 2011 Feb; 53(1357):12. PubMed ID: 21304445
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial overview: Gastrointestinal: New frontiers in therapeutics for GI diseases and disorders-from microRNAs to novel pharmaceutics, to low FODMAP diets and microbiome.
    Christofi FL; Bharucha AE
    Curr Opin Pharmacol; 2017 Dec; 37():iv-viii. PubMed ID: 29224799
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of digestive disorders of different etiology].
    Klobe R
    Z Allgemeinmed; 1972 Apr; 48(11):566-7. PubMed ID: 5067948
    [No Abstract]   [Full Text] [Related]  

  • 20. Curcumin improves learning and memory ability and its neuroprotective mechanism in mice.
    Pan R; Qiu S; Lu DX; Dong J
    Chin Med J (Engl); 2008 May; 121(9):832-9. PubMed ID: 18701050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.